Isopropylamine → HCID 178435001, compound

HRID 1695482Notes

Reaction equation

HRID 1695482 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:12](/[CH:13]=[CH:14]/[C:15]3[CH:16]=[C:17]([C:20]([OH:22])=O)[NH:18][N:19]=3)=[C:11]([CH3:23])[O:10][N:9]=2)=[CH:4][CH:3]=1.[CH:24]([NH2:27])([CH3:26])[CH3:25]>>[CH:24]([NH:27][C:20]([C:17]1[NH:18][N:19]=[C:15](/[CH:14]=[CH:13]/[C:12]2[C:8]([C:5]3[CH:4]=[CH:3][C:2]([F:1])=[CH:7][CH:6]=3)=[N:9][O:10][C:11]=2[CH3:23])[CH:16]=1)=[O:22])([CH3:26])[CH3:25]

Participants

3

Procedure

As described for example 132, 5-{(E)-2-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-yl]-vinyl}-2H-pyrazole-3-carboxylic acid was converted, using isopropylamine instead of morpholine, to the title compound (28 mg, 53%) which was obtained as an off white solid. MS: m/e=355.2 [M+H]+.

Sources & evidence

ORD record
ord-8c44049fcf3243669ce9ea5d4e771344
Source dataset
uspto-grants-2012_04
Patent number
US08163728B2

Reaction notes

Loading…